Adhera Therapeutics, Inc. Convertible Notes Payable, Current
Adhera Therapeutics, Inc. had Convertible Notes Payable, Current of $1.17 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2023-11-20
- 2023-09-30: Convertible Notes Payable, Current $1.17M.
- 2023-06-30: Convertible Notes Payable, Current $1.18M.
- 2023-03-31: Convertible Notes Payable, Current $1.23M.
- 2022-12-31: Convertible Notes Payable, Current $1.25M; Convertible Notes Payable, Current as first filed $1.25M.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2023-09-30 | $1.17M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $1.25M 10-Q · filed 2023-11-20 | $1.25M 10-K · filed 2023-03-31 |
| 2022-09-30 | $1.12M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.04M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.15M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $986.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $862.00K 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $817.00K 10-Q · filed 2021-08-23 | |
| 2020-12-31 | $641.00K 10-K · filed 2022-04-15 | |
| 2017-09-30 | $406.32K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $401.28K 10-Q · filed 2017-08-14 |